Pieter W. Kamphuisen

Tergooi — Netherlands

Medicine · Health Sciences

71h-index20.9kcitations414works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(234), Atrial Fibrillation Management and Outcomes(99), Blood Coagulation and Thrombosis Mechanisms(57), Central Venous Catheters and Hemodialysis(49), Hemophilia Treatment and Research(31)

Publications410 total

Management of recurrent venous thromboembolism during anticoagulant treatment in patients with cancer: a prospective cohort study
Journal of Thrombosis and Haemostasis·2025· 1 citedOpen Access
Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study
Research and Practice in Thrombosis and Haemostasis·2025· 1 citedOpen Access
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysis
Scientific Reports·2025· 1 citedOpen Access
The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review
Current Opinion in Hematology·2025· 1 citedOpen Access
Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study
Journal of Thrombosis and Haemostasis·2024· 7 citedOpen Access
Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction Model
Thrombosis and Haemostasis·2024· 7 citedOpen Access
European guidelines on peri-operative venous thromboembolism prophylaxis: first update.
European Journal of Anaesthesiology·2024· 1 citedOpen Access
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study
Journal of Thrombosis and Haemostasis·2024· 6 citedOpen Access
Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial
Research and Practice in Thrombosis and Haemostasis·2024· 5 citedOpen Access
Discharge from the emergency department and outpatient clinic in cancer patients with acute symptomatic and incidental pulmonary embolism: A multicenter retrospective cohort study
Thrombosis Research·2023· 5 citedOpen Access
Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study
TH Open·2023Open Access
OC 46.1 Absolute Quantitative Proteomics for Occult Cancer Screening in Patient with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study
Research and Practice in Thrombosis and Haemostasis·2023· 1 citedOpen Access
OC 64.4 Prediction of on Treatment Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-Analysis of Randomized Controlled Trials
Research and Practice in Thrombosis and Haemostasis·2023Open Access
PB0479 The ABC-Bleeding Score for Prediction of On-Treatment Clinically Relevant Bleeding in Patients with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study
Research and Practice in Thrombosis and Haemostasis·2023Open Access
OC 71.2 Discharging Cancer Patients with Acute Pulmonary Embolism from the Emergency Department: A Multicenter Cohort Study
Research and Practice in Thrombosis and Haemostasis·2023· 1 citedOpen Access
Using Coronary Artery Calcium Score as Diagnostic Tool in Symptomatic Chronic Coronary Syndrome Patients in a Real-Life Setting
Vascular Health and Risk Management·2023· 1 citedOpen Access
Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort study
Journal of Thrombosis and Haemostasis·2023· 10 citedOpen Access
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
Journal of Thrombosis and Haemostasis·2023· 9 citedOpen Access
Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer
Thrombosis Research·2023· 4 citedOpen Access
Pulmonary embolism risk in critically ill patients with COVID-19: an instrumental variable analysis using differential application of thromboprophylaxis guidelines
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Menno V. Huisman(8), Harry R. Büller(7), Walter Ageno(6), Renée A. Douma(6), Paul L. den Exter(5), Jeroen Eikenboom(5), Jeffrey I. Weitz(4), Cecilia Becattini(4), Josien van Es(4), Grégoire Le Gal(4), Rogier M. Bertina(4), Patrick M. Bossuyt(4), Nick van Es(4), Giancarlo Agnelli(4), Anthonius de Boer(3), John W. Eikelboom(3), Stephan Glund(3), Peter Verhamme(3), Robert Dubiel(3), Elaine M. Hylek(3)